These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 1341444)

  • 1. Changes of serum neopterin, beta 2-microglobulin and interferon-gamma in patients with chronic hepatitis C treated with interferon-alpha 2b.
    Fuchs D; Norkrans G; Wejstal R; Reibnegger G; Weiss G; Weiland O; Schvarcz R; Fryden A; Wachter H
    Eur J Med; 1992; 1(4):196-200. PubMed ID: 1341444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced serum levels of beta-2-microglobulin, neopterin, and interferon-gamma in patients treated with recombinant tumor necrosis factor-alpha.
    Aulitzky WE; Tilg H; Herold M; Berger M; Vogel W; Judmaier G; Gastl G; Mull B; Flener R; Wiegele J
    J Interferon Res; 1988 Oct; 8(5):655-64. PubMed ID: 3148671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum and urinary neopterin levels in patients with chronic active hepatitis B treated with interferon.
    Daito K; Suou T; Kawasaki H
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):303-16. PubMed ID: 8008980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of cytokines and cytokine-induced secondary messages in sera of patients after liver transplantation.
    Tilg H; Vogel W; Aulitzky WE; Herold M; Königsrainer A; Margreiter R; Huber C
    Transplantation; 1990 Jun; 49(6):1074-80. PubMed ID: 2163132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilot study of natural human interleukin-2 in patients with chronic hepatitis B. Immunomodulatory and antiviral effects.
    Tilg H; Vogel W; Tratkiewicz J; Aulitzky WE; Herold M; Gruber M; Geissler D; Umlauft F; Judmaier G; Schwulera U
    J Hepatol; 1993 Sep; 19(2):259-67. PubMed ID: 8301059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon-alpha-induced biologic modifications in patients with chronic myelogenous leukemia.
    Liberati AM; Horisberger MA; Garofani P; De Angelis V; Ferrajoli A; Di Clemente F; Caricchi P; Adiuto D; Fedeli L; Palumbo B
    J Interferon Res; 1994 Dec; 14(6):349-55. PubMed ID: 7897254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum levels of soluble immune factors and pathogenesis of chronic hepatitis C, and their relation to therapeutic response to interferon-alpha.
    Quiroga JA; Martin J; Pardo M; Carreño V
    Dig Dis Sci; 1994 Nov; 39(11):2485-96. PubMed ID: 7956620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum lipid levels during interferon therapy in patients with chronic hepatitis C.
    Picciotto A; Bertolini S; Bardellini E; Borro P; Borzone S; Masturzo P; Pireddu M; Sinelli N; Celle G
    J Interferon Cytokine Res; 1995 Aug; 15(8):703-4. PubMed ID: 8528942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged interferon-gamma application by subcutaneous infusion in cancer patients: differential response of serum CD14, neopterin, and monocyte HLA class I and II antigens.
    Landmann R; Ludwig C; Wesp M; Fisscher A; Obrist R; Knüsli C; Denz H; Obrecht JP
    J Interferon Res; 1992 Apr; 12(2):103-11. PubMed ID: 1374454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
    Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Changes in serum levels of beta 2-microglobulin, neopterin and 2',5'-oligoadenylate synthase activity during clearance of hepatitis B virus with or without acute phase in transaminases].
    Carreño García V; Hernández-Guío C; Bartolomé Nebreda J; Quiroga Estévez JA
    Rev Esp Enferm Dig; 1993 Mar; 83(3):169-75. PubMed ID: 7683894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different lymphoid cell populations produce varied levels of neopterin, beta 2-microglobulin and soluble IL-2 receptor when stimulated with IL-2, interferon-gamma or tumour necrosis factor-alpha.
    Hofmann B; Bass H; Nishanian P; Faisal M; Figlin RA; Sarna GP; Fahey JL
    Clin Exp Immunol; 1992 Jun; 88(3):548-54. PubMed ID: 1606739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection.
    Fuchs D; Möller AA; Reibnegger G; Werner ER; Werner-Felmayer G; Dierich MP; Wachter H
    Immunol Lett; 1991 Jun; 28(3):207-11. PubMed ID: 1909303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between neopterin and beta-2-microglobulin levels and HIV status in Romanian orphanage children.
    Zaknun D; DiFranco M; Oswald HP; Zaknun J; Mayersbach P; Vuja E; Wachter H; Fuchs D
    Wien Klin Wochenschr; 1993; 105(10):284-8. PubMed ID: 8517058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A direct comparison of biological response modulation and clinical side effects by interferon-beta ser, interferon-gamma, or the combination of interferons beta ser and gamma in humans.
    Schiller JH; Storer B; Paulnock DM; Brown RR; Datta SP; Witt PL; Borden EC
    J Clin Invest; 1990 Oct; 86(4):1211-21. PubMed ID: 2120284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tolerability of interferon alpha-2b, a possible new treatment of active Crohn's disease.
    Davidsen B; Munkholm P; Schlichting P; Nielsen OH; Krarup H; Bonnevie-Nielsen V
    Aliment Pharmacol Ther; 1995 Feb; 9(1):75-9. PubMed ID: 7766748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of serological markers for cellular immune activation in patients with dilated cardiomyopathy and chronic myocarditis.
    Samsonov M; Fuchs D; Reibnegger G; Belenkov JN; Nassonov EL; Wachter H
    Clin Chem; 1992 May; 38(5):678-80. PubMed ID: 1582019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum concentrations of sIL-2R, IL-6, TGF-beta1, neopterin, and zinc in chronic hepatitis C patients treated with interferon-alpha.
    Grüngreiff K; Reinhold D; Ansorge S
    Cytokine; 1999 Dec; 11(12):1076-80. PubMed ID: 10623433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship and prognostic value of endogenous interferon-alpha, beta 2-microglobulin, and neopterin serum levels in patients with Kaposi sarcoma and AIDS.
    Krown SE; Niedzwiecki D; Bhalla RB; Flomenberg N; Bundow D; Chapman D
    J Acquir Immune Defic Syndr (1988); 1991; 4(9):871-80. PubMed ID: 1895208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous IFN-gamma during human bone marrow transplantation. Analysis of serum levels of interferon and interferon-dependent secondary messages.
    Niederwieser D; Herold M; Woloszczuk W; Aulitzky W; Meister B; Tilg H; Gastl G; Bowden R; Huber C
    Transplantation; 1990 Oct; 50(4):620-5. PubMed ID: 2171163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.